Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      • Home
      • Medical Dialogues...

      Articles By : Medical Dialogues Bureau

      Fighting Counterfeit Drugs: NITI Aayog, Oracle, Apollo Hospitals Strides Pharma Join Hands

      Fighting Counterfeit Drugs: NITI Aayog, Oracle, Apollo Hospitals Strides Pharma Join Hands

      Medical Dialogues Bureau29 Sept 2018 2:05 PM IST
      NITI Aayog has the partnership with Apollo Hospital, Oracle, Strides Pharma work to pilot a real drug supply chain using the blockchain software...
      UK biotech raises bumper $2 billion, despite Brexit blues

      UK biotech raises bumper $2 billion, despite Brexit blues

      Medical Dialogues Bureau29 Sept 2018 10:15 AM IST
      LONDON: Britain's biotechnology industry has raised a bumper 1.56 billion pounds ($2.05 billion) in the first eight months of this year, surpassing...
      Sun Pharma looks to grow complex generics, specialty products biz faster

      Sun Pharma looks to grow complex generics, specialty products biz faster

      Medical Dialogues Bureau29 Sept 2018 9:20 AM IST
      The speciality initiative will entail incurring up-front cost and investments for long-term benefits,New Delhi: Drug major Sun Pharma has recently...
      USFDA approves Vizimpro drug to treat Lung cancer

      USFDA approves Vizimpro drug to treat Lung cancer

      Medical Dialogues Bureau29 Sept 2018 9:15 AM IST
      Vizimpro is a prescription medicine used to treat non-small cell lung cancer (NSCLC) that has spread to other parts of the body.Banglore: Pfizer Inc...
      Metropolis Healthcare to aim for Rs 2000 crore plus IPO: Report

      Metropolis Healthcare to aim for Rs 2000 crore plus IPO: Report

      Medical Dialogues Bureau28 Sept 2018 3:30 PM IST
      Mumbai: Metropolis Healthcare, one of the large players in the medical diagnostic segment with its chain pathology labs and diagnostics services has...
      Oppenheimer sells Apollo Hospital shares worth Rs 146 cr

      Oppenheimer sells Apollo Hospital shares worth Rs 146 cr

      Medical Dialogues Bureau28 Sept 2018 11:11 AM IST
      OppenheimerFunds sold 14,00,178 shares amounting to over 1 per cent of the total shareholding of Apollo Hospitals for a total consideration of Rs...
      Unfair business ways: CCI Fine on Medical Device maker Esaote

      Unfair business ways: CCI Fine on Medical Device maker Esaote

      Medical Dialogues Bureau28 Sept 2018 10:20 AM IST
      New Delhi: The Competition Commission has penalised Italy's Esaote SpA and its group entity Esaote Asia Pacific Diagnostic for unfair business...
      U.S. judge dismisses Teva lawsuits against Lilly on migraine drug

      U.S. judge dismisses Teva lawsuits against Lilly on migraine drug

      Medical Dialogues Bureau28 Sept 2018 9:45 AM IST
      BOSTON: A federal judge recently dismissed a pair of patent infringement lawsuits by Teva Pharmaceutical Industries Ltd that sought to block Eli Lilly...
      Nuplazid: New drug to treat Parkinsons disease

      Nuplazid: New drug to treat Parkinson's disease

      Medical Dialogues Bureau28 Sept 2018 9:20 AM IST
      As the first drug approved to treat hallucinations and delusions associated with PDP, Nuplazid was immediately popular. But lingering concerns about...
      Govt Issues Guidelines on Good Distribution Practices for pharmaceutical products, invites comments

      Govt Issues Guidelines on Good Distribution Practices for pharmaceutical products, invites comments

      Medical Dialogues Bureau27 Sept 2018 3:21 PM IST
      All the stakeholders are requested to forward their comments/ suggestions within a period of three weeks through e-mail to dci@nic.in...
      STRIKE ALERT: Chemists across India to keep doors shut on 28 September

      STRIKE ALERT: Chemists across India to keep doors shut on 28 September

      Medical Dialogues Bureau27 Sept 2018 2:07 PM IST
      We are observing one day strike on Friday, September 28, to protest any move by the government allowing the sale of medicines through an internet or...
      Columbia Asia to Invest 210 Million Dollar across Asia, India by 2020

      Columbia Asia to Invest 210 Million Dollar across Asia, India by 2020

      Medical Dialogues Bureau27 Sept 2018 10:45 AM IST
      Bangalore: Columbia Asia, a leading hospital chain in Asia, is all set to expand operations across Asia and India by 2020, utilizing the 210 million...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok